COX II inhibitorsBROOKS, Peter.Current pharmaceutical design. 2002, Vol 8, Num 12, issn 1381-6128, 71 p.Serial Issue

Allograft options : Stickin' with the one that brung YaBROOKS, Peter J.Orthopedics (Thorofare). 2005, Vol 28, Num 9, pp 969-970, issn 0147-7447, 2 p.Article

Undergraduate teaching of complementary medicineBROOKS, Peter M.Medical journal of Australia. 2004, Vol 181, Num 5, issn 0025-729X, p. 275Article

COX-2 inhibitorsBROOKS, Peter M.Current pharmaceutical design. 2000, Vol 6, Num 17, issn 1381-6128, 88 p.Serial Issue

The Jumbo Cup : The 95% SolutionBROOKS, Peter J.Orthopedics (Thorofare). 2008, Vol 31, Num 9, pp 913-913, issn 0147-7447, 1 p.Article

The impact of chronic illness: partnerships with other healthcare professionalsBROOKS, Peter M.Medical journal of Australia. 2003, Vol 179, Num 5, pp 260-262, issn 0025-729X, 3 p.Article

Stem cells in the aetiopathogenesis and therapy of rheumatic diseaseMOORE, John; TYNDALL, Alan; BROOKS, Peter et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 711-726, issn 1521-6942Article

Semi-volatile organic compounds in the Campaspe River system (Victoria, Australia)PARNIS, Craig; BROOKS, Peter.Water research (Oxford). 2001, Vol 35, Num 8, pp 1861-1868, issn 0043-1354Article

PharmacopathogenesisBREEDVELD, Ferry; BROOKS, Peter.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, issn 1521-6942, 196 p.Serial Issue

Innovative Use of Povidone-Iodine to Guide Burn Wound Debridement and Predict the Success of Biobrane as a Definitive Treatment for BurnsYU SIN LAU; BROOKS, Peter.Advances in skin & wound care (Print). 2014, Vol 27, Num 3, pp 111-113, issn 1527-7941, 3 p.Article

Characterization of carbonaceous combustion residues: II. Nonpolar organic compoundsFERNANDES, Milena B; BROOKS, Peter.Chemosphere (Oxford). 2003, Vol 53, Num 5, pp 447-458, issn 0045-6535, 12 p.Article

Gas gangreneANESTI, Ekaterini; BROOKS, Peter; MAJUMDER, S et al.Annals of emergency medicine. 2007, Vol 50, Num 1, issn 0196-0644, 14, 33 [2 p.]Article

International consensus conference on outcome measures in rheumatology clinical trialsBOERS, Maarten; STRAND, Vibeke; SIMON, Lee. S et al.Journal of rheumatology. 2007, Vol 34, Num 3, pp 599-599, issn 0315-162X, 1 p.Conference Paper

Temporal exposure of cryptic collagen epitopes within ischemic muscle during hindlimb reperfusionGAGNE, Paul J; TIHONOV, Nikita; XIALOU LI et al.The American journal of pathology. 2005, Vol 167, Num 5, pp 1349-1359, issn 0002-9440, 11 p.Article

Patient based method of assessing adverse events in clinical trials in rheumatology : The revised Stanford Toxicity indexWELCH, Vivian; SINGH, Gurkirpal; KRISTJANSSON, Betsy et al.Journal of rheumatology. 2001, Vol 28, Num 5, pp 1188-1191, issn 0315-162XConference Paper

Metalloproteases and inhibitors in arthritic diseasesMARTEL-PELLETIER, Johanne; WELSCH, Dean J; PELLETIER, Jean-Pierre et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 805-829, issn 1521-6942Article

The role of nitric oxide in tissue destructionABRAMSON, Steven B; AMIN, Ashok R; CLANCY, Robert M et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 831-845, issn 1521-6942Article

Peripheral blood stem cell transplantation for rheumatoid arthritis : Australian experienceMOORE, John; MILLIKEN, Sam; MA, David et al.Journal of rheumatology. Supplement. 2001, Vol 28, Num 64, pp 8-12, issn 0380-0903Conference Paper

Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia: A Randomized Controlled TrialCOOMBES, Brooke K; BISSET, Leanne; BROOKS, Peter et al.JAMA, the journal of the American Medical Association. 2013, Vol 309, Num 5, pp 461-469, issn 0098-7484, 9 p.Article

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010SALOMON, Joshua A; VOS, Theo; REYNA FARJE, Mario et al.Lancet (British edition). 2013, Vol 380, Num 9859, pp 2129-2143, issn 0140-6736, 15 p.Article

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreementHOY, Damian; BROOKS, Peter; WOOLF, Anthony et al.Journal of clinical epidemiology. 2012, Vol 65, Num 9, pp 934-939, issn 0895-4356, 6 p.Article

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical TrialsFELSON, David T; SMOLEN, Josef S; BROOKS, Peter et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 3, pp 404-413, issn 0003-4967, 10 p.Article

Fragmentation-free LC-MS can identify hundreds of proteinsBOCHET, Pascal; RÜGHEIMER, Frank; GUINA, Tina et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 1, pp 22-32, issn 1615-9853, 11 p.Article

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisMOORE, John; BROOKS, Peter; LANGLANDS, Bob et al.Arthritis and rheumatism. 2002, Vol 46, Num 9, pp 2301-2309, issn 0004-3591Article

Vascular mechanisms in osteoarthritisGHOSH, Peter; CHERAS, Phillip A.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 693-709, issn 1521-6942Article